8-K COMP COMMITTEE OPTIONS

Company

GYRE THERAPEUTICS, INC.

Filed

July 14, 2017

Period of Report

July 11, 2017

Accession Number

0001564590-17-013442

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →